To Wean or Not to Wean: That is the Question

Affiliations

Editorial

Melissa L Mannion et al. Arthritis Care Res (Hoboken). 2023 Apr.

. 2023 Apr;75(4):712-714.

doi: 10.1002/acr.24992. Epub 2022 Nov 9.

No abstract available

Comment on

Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry.
Ringold S, Dennos AC, Kimura Y, Beukelman T, Shrader P, Phillips TA, Kohlheim M, Schanberg LE, Yeung RSM, Horton DB; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Ringold S, et al. Arthritis Care Res (Hoboken). 2023 Apr;75(4):715-723. doi: 10.1002/acr.24994. Epub 2022 Dec 21. Arthritis Care Res (Hoboken). 2023. PMID: 35921198

1. Reiff DD, Stoll ML, Cron RQ. Precision medicine in juvenile idiopathic arthritis: has the time arrived? Lancet Rheumatol 2021;3:e808-17.
1. Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J 2014;12:13.
1. Mannion ML, Cron RQ. Therapeutic strategies for treating juvenile idiopathic arthritis. Curr Opin Pharmacol 2022;64:102226.
1. Horton DB, Salas J, Wec A, et al. Making decisions about stopping medicines for well-controlled juvenile idiopathic arthritis: a mixed-methods study of patients and caregivers. Arthritis Care Res (Hoboken) 2021;73:374-85.
1. Ringold S, Dennos AC, Kimura Y, et al, on behalf of the CARRA Registry Investigators. Disease recapture rates after medication discontinuation and flare in JIA: an observational study within the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res (Hoboken) 2023;75:714-23. doi: http://onlinelibrary.wiley.com/doi/10.1002/acr.24994/abstract.